-DNA The 97th constitutional amendment made RTI activists happy because they believed that it brought co-operative housing societies under the purview of the RTI Act. In February, the state passed its own ordinance implementing the amendment. State chief information commissioner Ratnakar Gaikwad does not stand with the activists' consensus. He spoke with dna's Ashutosh Shukla about cooperative societies, pending second appeals and voluntary disclosure. Your opinion on housing societies coming under RTI? I don't think that...

-The Indian Express On January 12 last year, RTI applicant Dinesh Suryavanshi had sought information related to class XI admissions under Right to Information (RTI) Act, 2005. Even after two appeals and a showcause notice issued to education department officials, he is still waiting for a response from them. "I wanted to know about the total number of seats reserved for SC, ST candidates, the stipulated seats in management courses and the...

-The Times of India The Delhi High Court on Thursday issued notice to the Attorney General on a plea that the office of the law officer be declared a "public authority" under the RTI Act as the appointment is according to the Constitution. Justice G S Sistani gave six weeks to the AG to reply while hearing an appeal filed by Delhi-based RTI activist Subhash Chandra Aggarwal against a decision of the...

-Civil Society Online Accreditation is the act of granting credit or recognition. It is to be preceded with a process where facts, figures and professional ethics are scrutinized so that the desired certification of competency, authority or credibility is presented. Only the best suited with the requisite track record are to find themselves in the approved list. In India, the much talked about and well critiqued initiative wherein consultants undertaking the responsibility...

-Live Mint SC rejects Novartis's patent plea for Glivec, says it does not meet any standard of novelty or inventiveness In a landmark judgement, India's apex court rejected Swiss drug maker Novartis AG's legal challenge aimed at securing a patent for blockbuster anti-cancer drug imatinib mesylate, branded Glivec in the country. The verdict, which is seen as a setback to multinational pharmaceutical companies operating in India, may influence a rash of pending disputes...